好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Data in brief: Factors associated with in-patient admission among stroke patients
General Neurology
P1 - Poster Session 1 (8:00 AM-9:00 AM)
6-024

To estimate the probability of admission among patients with stroke evaluated in the emergency department.

 

Misuse of inpatient resources is a central problem to the healthcare system. Elucidating certain trends behind inpatient admission in patients with a cerebral infarction may reveal opportunities to improve safe and effective stroke triage and throughput.

 

We retrospectively queried the 2019 National Emergency Department Sample Database for patients who had a cerebral infarction. Disposition from the emergency department was classified into one of several categories: routine discharge, discharge against medical advice, transfer to short term hospital, home care, death, and admission to the inpatient setting. The primary endpoint was inpatient admission versus all other dispositions and was assessed using multivariable logistic regression after adjustment for key patient characteristics, hospital teaching and trauma status, geographic regions, insurance status.

 

Of the 598,818 patients diagnosed with acute cerebral infarction, 471,464 (78.7%) were admitted to an inpatient acute care facility. Patients with private insurance (OR 0.85, 95%CI 0.78-0.93) or self-pay (OR 0.80, 95%CI 0.70-0.91) had lower odds of being admitted, compared to Medicare patients. Compared to Metropolitan Non-Teaching hospitals, Metropolitan teaching hospitals (OR 1.59, 95%CI 1.27-1.97) had a higher odds of admission, whereas non-metropolitan hospitals (OR 0.35, 95%CI 0.27-0.44) had a lower odds of admission. Additionally, compared to non-trauma hospitals, patients evaluated at level 1 trauma centers (OR 3.17, 95%CI 2.48-4.05) had higher odds of admission.  In addition, hyperlipidemia (OR 2.25, 95%CI 2.09-2.42), overweight (OR 2.15, 95%CI 1.90-2.42), and hypertension (OR 1.55, 95%CI 1.47-1.63) were independently associated with a higher odds of admission.

Optimization of certain high-risk comorbidities may not only reduce stroke incidence, but they may reduce inpatient utilization. Further, differences in admission based on patient-level socioeconomic factors warrant greater exploration to minimize disparities in access to acute care.

 
Authors/Disclosures
Jared C. Wolfe, MD (Cooper Medical School)
PRESENTER
Dr. Wolfe has nothing to disclose.
Karan Patel, MD (Cooper Medical School of Rowan University) Mr. Patel has nothing to disclose.
No disclosure on file
Solomon Oak, MD Mr. Oak has nothing to disclose.
Christopher G. Favilla, MD (University of Pennsylvania) The institution of Dr. Favilla has received research support from National Institutes of Health. The institution of Dr. Favilla has received research support from American Heart Association. The institution of Dr. Favilla has received research support from OpenWater, Inc..
Jesse Thon, MD (Cooper University Hospital) An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.